Prospects of IL-2 in Cancer Immunotherapy

المؤلفون المشاركون

Rasool, Mahmood
Choudhry, Hani
Zamzami, Mazin A.
Wu, Wei
Abdulaal, Wesam H.
Helmi, Nawal
Zeyadi, Mustafa
Warsi, Mohiuddin K.
Jamal, Mohammad Sarwar
Mahmoud, Maged Mostafa

المصدر

BioMed Research International

العدد

المجلد 2018، العدد 2018 (31 ديسمبر/كانون الأول 2018)، ص ص. 1-7، 7ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2018-05-06

دولة النشر

مصر

عدد الصفحات

7

التخصصات الرئيسية

الطب البشري

الملخص EN

IL-2 is a powerful immune growth factor and it plays important role in sustaining T cell response.

The potential of IL-2 in expanding T cells without loss of functionality has led to its early use in cancer immunotherapy.

IL-2 has been reported to induce complete and durable regressions in cancer patients but immune related adverse effects have been reported (irAE).

The present review discusses the prospects of IL-2 in immunotherapy for cancer.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Choudhry, Hani& Helmi, Nawal& Abdulaal, Wesam H.& Zeyadi, Mustafa& Zamzami, Mazin A.& Wu, Wei…[et al.]. 2018. Prospects of IL-2 in Cancer Immunotherapy. BioMed Research International،Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1129459

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Choudhry, Hani…[et al.]. Prospects of IL-2 in Cancer Immunotherapy. BioMed Research International No. 2018 (2018), pp.1-7.
https://search.emarefa.net/detail/BIM-1129459

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Choudhry, Hani& Helmi, Nawal& Abdulaal, Wesam H.& Zeyadi, Mustafa& Zamzami, Mazin A.& Wu, Wei…[et al.]. Prospects of IL-2 in Cancer Immunotherapy. BioMed Research International. 2018. Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1129459

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1129459